Literature DB >> 7926873

Morphological study on glucocorticoid-induced cataract in developing chick embryo.

S Uga1, H Nishigori, S Ishikawa.   

Abstract

Nishigori et al. reported a transient cataract model after administering glucocorticoid to a 15-day-old chick. Biochemically, the mechanism of onset of this cataract was though to be related to damage caused by the formation of oxidative stresses and by a protein-water phase separation. There appear to be no reports on changes in the fine structure. After hydrocortisone succinate sodium was administered to 15-day-old chick embryos, the lenses were removed at 12, 24, 30, 48, 72 and 96 h and put in 4% glutaraldehyde. The specimens were examined by light, transmission and scanning electron microscopy. Twelve to 24 h after administration to chick embryos, lens fibers containing electron-dense cytoplasm began to appear in the bow area of the equator and were still present thereafter. Thirty to 48 h after administration, numerous vacuoles of varying sizes began to appear in the lens in sites corresponding to the opaque region. These vacuoles, ranging from 2 to 8 microns in diameter, were distributed in the intercellular spaces between the lens fibers. The vacuoles had disappeared by 96 h after administration, but during that period, the height of the epithelial cells in the equatorial region and the elongation of the equatorial lens fibers had become irregular. Transient opacity was due to the presence of vacuoles of various sizes, occurring in the intercellular space between the lens fibers around the lens nucleus. Moreover, the effect of glucocorticoid administration was noted in the lens epithelium and the lens fibers in the equatorial region.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926873     DOI: 10.1007/bf00186583

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Examination of lenses of steroid-treated rats.

Authors:  L VON SALLMANN; L L CARAVAGGIO; E M COLLINS; K WEAVER
Journal:  Am J Ophthalmol       Date:  1960-12       Impact factor: 5.258

2.  Glucocorticoid-induced cataract in chick embryo monitored by Raman spectroscopy.

Authors:  A Mizuno; H Nishigori; M Iwatsuru
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-01       Impact factor: 4.799

3.  Corticosteroid-induced cataract and palatoschisis in the mouse fetus.

Authors:  A Rogoyski; Z Trzcinska-Dabrowska
Journal:  Am J Ophthalmol       Date:  1969-07       Impact factor: 5.258

4.  An animal model for cataract research: cataract formation in developing chick embryo by glucocorticoid.

Authors:  H Nishigori; J W Lee; M Iwatsuru
Journal:  Exp Eye Res       Date:  1983-04       Impact factor: 3.467

5.  delta-crystallin synthesis and vacuole formation during induced opacification of cultured embryonic chick lenses.

Authors:  T Shinohara; W G Robison; J Piatigorsky
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-06       Impact factor: 4.799

6.  Experimental cataracts following long-term administration of corticosteroids.

Authors:  A Tarkkanen; R Esilä; M Liesmaa
Journal:  Acta Ophthalmol (Copenh)       Date:  1966

7.  Posterior subcapsular cataracts: histopathologic study of steroid-associated cataracts.

Authors:  J V Greiner; L T Chylack
Journal:  Arch Ophthalmol       Date:  1979-01

8.  Analysis of glucose levels during glucocorticoid-induced cataract formation in chick embryos.

Authors:  H Nishigori; J W Lee; Y Yamauchi; K Maruyama; M Iwatsuru
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-01       Impact factor: 4.799

9.  Image analysis of the lens opacities induced in developing chick embryo by glucocorticoid.

Authors:  M A Babizhayev; A V Zhukotskii; A A Sologub
Journal:  Exp Eye Res       Date:  1992-10       Impact factor: 3.467

10.  The alteration of lipid peroxide in glucocorticoid-induced cataract of developing chick embryos and the effect of ascorbic acid.

Authors:  H Nishigori; J W Lee; Y Yamauchi; M Iwatsuru
Journal:  Curr Eye Res       Date:  1986-01       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.